Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma

Authors :: Guilherme Nader Marta
Leonardo G. da Fonseca
Maria Ignez Braghiroli
Fernando Moura
Paulo M. Hoff
Jorge Sabbaga
Source :: Clinics, Vol 76 (2021)
Publication Year :: 2021
Publisher :: Elsevier España, 2021.
Abstract: OBJECTIVES: To evaluate the efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma (HCC). METHODS: We analyzed data from a cohort of patients with advanced HCC treated using systemic treatment according to the local institutional protocol. Patients were divided into two groups, Group A, individuals

Subjects :: Hepatocellular Carcinoma
Older Adults
Sorafenib
Safety
Efficacy
Medicine (General)
R5-920

Full Text Access

Tools